The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123397833 12339783 3 F 201604 20160916 20160506 20160923 EXP CA-ALEXION PHARMACEUTICALS INC-A201603199 ALEXION 76.52 YR M Y 77.00000 KG 20160923 OT CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123397833 12339783 1 PS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 600 MG, QW AB7976C 125166 600 MG CONCENTRATE FOR SOLUTION FOR INFUSION /wk
123397833 12339783 2 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W AB7976C 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
123397833 12339783 3 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W AD9299B04 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
123397833 12339783 4 SS SOLIRIS ECULIZUMAB 1 Intravenous (not otherwise specified) 900 MG, Q2W AE7317B04 125166 900 MG CONCENTRATE FOR SOLUTION FOR INFUSION QOW
123397833 12339783 5 C RAMIPRIL. RAMIPRIL 1 Oral 5 MG, QD 0 5 MG QD
123397833 12339783 6 C ATORVASTATIN ATORVASTATIN 1 Oral 20 MG, QD 0 20 MG QD
123397833 12339783 7 C TYLENOL ACETAMINOPHEN 1 Oral NIGHT TIME 1 TAB, HS, PRN 0 /yr
123397833 12339783 8 C PENICILLIN /00000901/ PENICILLIN G 1 Oral 300 MG, BID 0 300 MG BID
123397833 12339783 9 C ORACORT /00031902/ 2 Oral UNK UNK, BID 0 BID
123397833 12339783 10 C EPREX ERYTHROPOIETIN 1 Unknown UNK, TIW 0 TIW
123397833 12339783 11 C ASA ASPIRIN 1 Oral 81 MG, QD 0 81 MG QD
123397833 12339783 12 C ACETAMINOPHEN. ACETAMINOPHEN 1 Oral UNK, PRN 0 /yr
123397833 12339783 13 C METOPROLOL. METOPROLOL 1 Oral 50 MG, BID 0 50 MG BID
123397833 12339783 14 C NITROGLYCERIN. NITROGLYCERIN 1 Unknown UNK, QD (12 TO 14HRS PER DAY) 0 QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123397833 12339783 1 Paroxysmal nocturnal haemoglobinuria
123397833 12339783 5 Product used for unknown indication
123397833 12339783 6 Product used for unknown indication
123397833 12339783 7 Product used for unknown indication
123397833 12339783 8 Prophylaxis
123397833 12339783 9 Product used for unknown indication
123397833 12339783 10 Product used for unknown indication
123397833 12339783 11 Product used for unknown indication
123397833 12339783 12 Product used for unknown indication
123397833 12339783 13 Product used for unknown indication
123397833 12339783 14 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
123397833 12339783 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
123397833 12339783 Anaemia
123397833 12339783 Blood lactate dehydrogenase increased
123397833 12339783 Fatigue
123397833 12339783 Haemoglobin decreased
123397833 12339783 Myocardial infarction

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123397833 12339783 1 20141007 20141027 0
123397833 12339783 2 20141103 0
123397833 12339783 3 20141103 0
123397833 12339783 4 20141103 0
123397833 12339783 8 20141027 0